Clinical utility of procalcitonin in severe odontogenic maxillofacial infection

Abstract Background Most of the maxillofacial infections are bacterial infections, and there is a possibility that systemic infections occur by maxillofacial infections. The aim of this study was to investigate the diagnostic value of procalcitonin in patients with odontogenic bacterial infections o...

Full description

Bibliographic Details
Main Authors: Ji-Kwan Kim, Jae-Hoon Lee
Format: Article
Language:English
Published: SpringerOpen 2021-01-01
Series:Maxillofacial Plastic and Reconstructive Surgery
Subjects:
Online Access:https://doi.org/10.1186/s40902-020-00288-x
_version_ 1818970882254569472
author Ji-Kwan Kim
Jae-Hoon Lee
author_facet Ji-Kwan Kim
Jae-Hoon Lee
author_sort Ji-Kwan Kim
collection DOAJ
description Abstract Background Most of the maxillofacial infections are bacterial infections, and there is a possibility that systemic infections occur by maxillofacial infections. The aim of this study was to investigate the diagnostic value of procalcitonin in patients with odontogenic bacterial infections of the maxillofacial region. Methods We enrolled sixty patients, who were admitted with odontogenic maxillofacial infection from September 2018 to March 2020. White blood cell counts, C-reactive protein, and procalcitonin concentrations were evaluated. Sixty patients were classified into two groups, sepsis and non-sepsis groups, based on systemic inflammatory response syndrome. A Student t test was performed to statistically analyze the difference in inflammatory markers between sepsis and non-sepsis groups. Results The mean procalcitonin values on admission were 7.24 ng/mL (range, 0.09–37.15 ng/mL) and 0.40 ng/mL (range, 0.02–4.94 ng/mL) in the sepsis group and non-sepsis group, respectively. The procalcitonin values between the two groups showed a significant difference (P < 0.05). The area under the curve of procalcitonin was 0.927 (P < 0.001), and the cutoff value of procalcitonin that maximizes the area under the curve was calculated to be 0.87 ng/mL. Conclusions According to our study, routine laboratory tests have insufficient accuracy in diagnosing sepsis syndrome. Therefore, it is strongly recommended to perform the procalcitonin test in patients with maxillofacial infection in addition to the conventional laboratory tests to diagnose the systemic inflammatory condition of the patients.
first_indexed 2024-12-20T14:43:32Z
format Article
id doaj.art-899688c7045046b387467bb174335709
institution Directory Open Access Journal
issn 2288-8586
language English
last_indexed 2024-12-20T14:43:32Z
publishDate 2021-01-01
publisher SpringerOpen
record_format Article
series Maxillofacial Plastic and Reconstructive Surgery
spelling doaj.art-899688c7045046b387467bb1743357092022-12-21T19:37:11ZengSpringerOpenMaxillofacial Plastic and Reconstructive Surgery2288-85862021-01-014311710.1186/s40902-020-00288-xClinical utility of procalcitonin in severe odontogenic maxillofacial infectionJi-Kwan Kim0Jae-Hoon Lee1Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook UniversityDepartment of Oral and Maxillofacial Surgery, College of Dentistry, Dankook UniversityAbstract Background Most of the maxillofacial infections are bacterial infections, and there is a possibility that systemic infections occur by maxillofacial infections. The aim of this study was to investigate the diagnostic value of procalcitonin in patients with odontogenic bacterial infections of the maxillofacial region. Methods We enrolled sixty patients, who were admitted with odontogenic maxillofacial infection from September 2018 to March 2020. White blood cell counts, C-reactive protein, and procalcitonin concentrations were evaluated. Sixty patients were classified into two groups, sepsis and non-sepsis groups, based on systemic inflammatory response syndrome. A Student t test was performed to statistically analyze the difference in inflammatory markers between sepsis and non-sepsis groups. Results The mean procalcitonin values on admission were 7.24 ng/mL (range, 0.09–37.15 ng/mL) and 0.40 ng/mL (range, 0.02–4.94 ng/mL) in the sepsis group and non-sepsis group, respectively. The procalcitonin values between the two groups showed a significant difference (P < 0.05). The area under the curve of procalcitonin was 0.927 (P < 0.001), and the cutoff value of procalcitonin that maximizes the area under the curve was calculated to be 0.87 ng/mL. Conclusions According to our study, routine laboratory tests have insufficient accuracy in diagnosing sepsis syndrome. Therefore, it is strongly recommended to perform the procalcitonin test in patients with maxillofacial infection in addition to the conventional laboratory tests to diagnose the systemic inflammatory condition of the patients.https://doi.org/10.1186/s40902-020-00288-xAbscessHead and neck infectionDental infectionsProcalcitoninSepsisSIRS
spellingShingle Ji-Kwan Kim
Jae-Hoon Lee
Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
Maxillofacial Plastic and Reconstructive Surgery
Abscess
Head and neck infection
Dental infections
Procalcitonin
Sepsis
SIRS
title Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
title_full Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
title_fullStr Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
title_full_unstemmed Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
title_short Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
title_sort clinical utility of procalcitonin in severe odontogenic maxillofacial infection
topic Abscess
Head and neck infection
Dental infections
Procalcitonin
Sepsis
SIRS
url https://doi.org/10.1186/s40902-020-00288-x
work_keys_str_mv AT jikwankim clinicalutilityofprocalcitonininsevereodontogenicmaxillofacialinfection
AT jaehoonlee clinicalutilityofprocalcitonininsevereodontogenicmaxillofacialinfection